TEDx Talks - Alzeimer's: Looking For a Cure | Prof. Dr. Mehmet Censev | TEDxYouth@BursaKoleji
The presentation provides an overview of Alzheimer's disease, a progressive brain disorder leading to memory impairment and cognitive decline. It is the most common cause of dementia in the elderly, characterized by brain changes such as neuron and synapse loss. The speaker explains the disease's progression from preclinical stages to severe Alzheimer's, highlighting symptoms like memory loss and cognitive difficulties. Major risk factors include age, genetics, and family history. Although the exact cause is unknown, potential factors include amyloid plaques and neurofibrillary tangles. Diagnosis involves cognitive tests and brain imaging, while treatment options focus on symptom management. FDA-approved medications include cholinesterase inhibitors and NMDA receptor inhibitors, with recent advancements in monoclonal antibodies targeting amyloid beta protein. Despite these treatments, there is no cure for Alzheimer's disease.
Key Points:
- Alzheimer's disease is a progressive brain disorder causing memory and cognitive decline, primarily affecting the elderly.
- Major risk factors include age, genetics, and family history, with women being more affected than men.
- Diagnosis involves cognitive tests and brain imaging, with recent blood tests for early detection.
- Current treatments focus on symptom management, including cholinesterase inhibitors and NMDA receptor inhibitors.
- Recent advancements include FDA-approved monoclonal antibodies targeting amyloid beta protein, though no cure exists.
Details:
1. 👋 Introduction and Talk Overview
- Alzheimer's disease is a debilitating disease with no current cure.
- The talk will focus on simplifying the complex nature of Alzheimer's disease.
- Key aspects of the disease such as its impact on patients and the latest research findings will be discussed.
2. 🧠 Understanding Alzheimer's Disease
- Alzheimer's disease is introduced, highlighting its impact as a progressive neurological disorder that affects memory and cognitive function.
- Symptoms include memory loss, confusion, difficulty with language, and changes in mood or behavior.
- Major risk factors include age, family history, genetics, and certain lifestyle factors such as lack of exercise and poor diet.
- Causes of Alzheimer's are linked to the buildup of amyloid plaques and tau tangles in the brain, leading to nerve cell damage and death.
- Diagnosis methods include neurological exams, cognitive tests, brain imaging techniques like MRI and CT scans, and laboratory tests to rule out other conditions.
3. 📉 Brain Changes and Atrophy
- Alzheimer's disease is a slowly progressive disorder that primarily affects memory, reasoning, planning, language, and perception, making it the leading cause of dementia among the elderly.
- The disease is characterized by significant brain changes, including the loss of neurons and synapses, particularly in the cerebral cortex and certain subcortical regions.
- These brain changes result in atrophy, which adversely impacts cognitive functions and daily living activities.
- Notable areas impacted by Alzheimer's include the hippocampus, which is crucial for memory, and the frontal cortex, which is essential for reasoning and planning.
- Understanding these changes is vital for developing targeted interventions to slow progression and manage symptoms.
4. 🔍 Neuronal Damage and Historical Insights
- Neuronal damage in Alzheimer's disease leads to significant atrophy in brain areas such as the hippocampus, frontal cortex, and temporal lobes.
- This atrophy affects essential functions including memory, language, and motor skills like walking and swallowing.
- Illustrations and neuroimaging highlight the stark contrast between healthy brains and those severely affected by Alzheimer's, showcasing the extent of neuronal loss and atrophy.
- Mechanisms of damage include the accumulation of amyloid plaques and tau tangles, which disrupt neuron function and communication.
- Case studies demonstrate the progressive nature of neuronal damage, correlating with clinical symptoms such as memory loss and cognitive decline.
5. 👵 Demographics and Diagnosis
- Brain atrophy indicates the death of neuronal cells, leading to significant shrinkage in brain structures, which is a key marker in diagnosing Alzheimer's disease.
- PET scans are instrumental in Alzheimer's diagnosis, as they provide visual comparisons between normal and affected brains, clearly showing inactive regions.
- The use of PET scans in Alzheimer's diagnosis is enhanced by the visibility of inactive brain areas, shown as blue and dark blue regions, which highlight the extent of neuronal inactivity.
6. 📋 Symptoms and Disease Progression
- Alzheimer's disease is primarily diagnosed in individuals over 65 years old, with twice as many women affected compared to men.
- Currently, 25 million people worldwide are affected, with projections to reach 100 million by 2050.
- Named after Dr. Alois Alzheimer, who in 1906 identified amyloid plaques and neurofibrillary tangles as key pathological features in the brain.
- Initial symptoms include memory loss, language problems, and unpredictable behavior, which progress over time to more severe cognitive and functional impairments.
7. ⏳ Stages and Risk Factors
7.1. Symptoms of Alzheimer's
7.2. Stages of Alzheimer's
7.3. Risk Factors for Alzheimer's
8. ⚠️ Risk Factors and Causes
8.1. Alzheimer's Disease Stages
8.2. Risk Factors for Alzheimer's Disease
9. 🔬 Pathological Changes and Synaptic Issues
9.1. Pathological Changes
9.2. Synaptic Issues
10. 🔗 Synaptic Dysfunction and Diagnosis
- Synapses are crucial for information transmission between nerves, occurring hundreds of thousands of times per millisecond in the brain.
- Interruption in synaptic transmission can lead to inability to learn new information and forgetting existing knowledge, indicating memory disruption.
- Alzheimer's disease is characterized by disruption and loss of synapses, leading to cognitive decline.
- Diagnostic techniques for synaptic dysfunction include imaging technologies like PET scans, which can detect synaptic density and integrity.
- Research suggests that early detection of synaptic dysfunction can aid in the timely management of Alzheimer's.
11. 🩺 Diagnostic Techniques
11.1. Traditional Diagnostic Methods for Alzheimer's Disease
11.2. Modern Diagnostic Advancements in Alzheimer's Disease
12. 💊 Current Treatments and Future Directions
- Monoclonal antibodies targeting beta-amyloid protein have been FDA-approved, emphasizing their role in addressing a core pathology in Alzheimer's disease.
- Cholinesterase inhibitors, addressing cholinergic dysfunction, have been a cornerstone of treatment since 1996, with galantamine approved in 2004.
- Memantine, approved to prevent excitotoxicity through NMDA receptor inhibition, complements the cholinesterase inhibitors.
- A combined treatment of memantine and donepezil, approved in 2014, reflects an integrative approach to Alzheimer's management.
- In 2023, a monoclonal antibody targeting beta-amyloid protein received full FDA approval, marking a significant advancement in preventing amyloid tangles and plaques.
- Future directions involve enhancing current treatment efficacy and developing novel therapeutics targeting additional pathways involved in Alzheimer's progression.